Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom
Open Access
- 23 January 2021
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 10 (2), 110
- https://doi.org/10.3390/antibiotics10020110
Abstract
Since first identified in late 2019, the acute respiratory syndrome coronavirus (SARS-CoV2) and the resulting coronavirus disease (COVID-19) pandemic has overwhelmed healthcare systems worldwide, often diverting key resources in a bid to meet unprecedented challenges. To measure its impact on national antimicrobial stewardship (AMS) activities, a questionnaire was designed and disseminated to antimicrobialstewardship leads in the United Kingdom (UK). Most respondents reported a reduction in AMS activity with 64% (61/95) reporting that COVID-19 had a negative impact on routine AMS activities. Activities reported to have been negatively affected by the pandemic include audit, quality improvement initiatives, education, AMS meetings, and multidisciplinary working including ward rounds. However, positive outcomes were also identified, with technology being increasingly used as a tool to facilitate stewardship, e.g., virtual meetings and ward rounds and increased the acceptance of using procalcitonin tests to distinguish between viral and bacterial infections. The COVID-19 pandemic has had a significant impact on the AMS activities undertaken across the UK. The long-term impact of the reduced AMS activities on incidence of AMR are not yet known. The legacy of innovation, use of technology, and increased collaboration from the pandemic could strengthen AMS in the post-pandemic era and presents opportunities for further development of AMS.Keywords
This publication has 30 references indexed in Scilit:
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up ChangesInvestigative Radiology, 2020
- The Novel Coronavirus Originating in Wuhan, ChinaJAMA, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative OrganismsCurrent Infectious Disease Reports, 2020
- Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017Infection Control & Hospital Epidemiology, 2020
- Macrolides in critically ill patients with Middle East Respiratory SyndromeInternational Journal of Infectious Diseases, 2019
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Secondary Bacterial Infections Associated with Influenza PandemicsFrontiers in Microbiology, 2017
- The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysisInfluenza and Other Respiratory Viruses, 2016